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Software for high-throughput cytometry assays <p>A software tool for the analysis of high-throughput cell-based assays is presented.</p>
Abstract
Highthroughput cell-based assays with flow cytometric readout provide a powerful technique for
identifying components of biologic pathways and their interactors. Interpretation of these large
datasets requires effective computational methods. We present a new approach that includes data
pre-processing, visualization, quality assessment, and statistical inference. The software is freely
available in the Bioconductor package prada. The method permits analysis of large screens to detect
the effects of molecular interventions in cellular systems.
Background
Cell-based assays permit functional profiling by probing the
roles of molecular actors in biologic processes or phenotypes.
They perturb the activity or abundance of gene products of
interest and measure the resulting effect in a population of
cells [1,2]. This can be done in principle for any gene or com-
bination of genes and any biologic process. There is a variety
of technologies that rely on the availability of genomic
resources such as full-length cDNA libraries [3-7], small
interfering RNA libraries [8-12], or collections of protein-spe-
cific interfering ligands (small chemical compounds) [13].
Loss-of-function assays that investigate the effect of silencing
or (partial) removal of a gene product or its activity [10] are
distinguished from gain-of-function assays, in which the
function of a gene product is analyzed after its abundance or
activity is increased [14].
Depending on the process of interest, phenotypes can be
assessed at various levels of complexity. In the simplest case
a phenotype is a yes/no alternative, such as survival versus
nonsurvival. More detail can be seen from a quantitative var-
iable such as the activity of a reporter gene measured on a flu-
orescent plate reader, and even more complex features can
involve time series or microscopic images. Although flow
cytometry is among the standard methods in immunology, it
has not been widely used in high-throughput screening, prob-
ably because of the lack of automation in data acquisition as
well as in data analysis. However, the technology has evolved
significantly in the recent past, and the latest generation of
instruments can be equipped with high-throughput screening
loaders that permit the measurement of large numbers of
samples in reasonable periods of time [15]. One major advan-
tage of flow cytometry is its ability to measure multiple
parameters for each individual cell of a cell population.
Whereas conventional cell-based assays are limited to record-
ing population averages, this approach allows the investiga-
tion of biologic variation at the single cell level.
A broad range of tools is available for analyzing flow cytome-
try data at a small or intermediate scale [16-18], but there is a
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lack of systematic computational approaches to analyze and
rationally interpret the amount of data produced in high-
throughput screens. Here we describe methods and software
to fulfill these requirements.
Results and discussion
We demonstrate our methodology on a dataset that was col-
lected in gain-of-function cellular screens probing for media-
tors of cell growth and division, in particular using assays for
DNA replication, apoptosis, and mitogen-activated protein
kinase (MAPK) signaling. The experiments were performed
in 96-well microtiter plates in which each well contained cells
transfected with a different overexpression construct. Along
with the phenotype of interest, the amount of overexpression
of the respective proteins was recorded via a fluorescent YFP
(yellow fluorescent protein) tag. In the following discussion
we refer to one microtiter plate as one experiment.
The flow cytometry data consist of four values for each cell:
two morphologic parameters and two fluorescence intensi-
ties. The morphologic parameters are forward light scatter
(FSC) and sideward light scatter (SSC), and they measure cell
size and cell granularity (the amount of light-impermeable
structures within the cell). One of the fluorescence channels
monitors emission from the YFP tag of the overexpressed
protein, whereas the other channel detects the fluorescence of
a fluorochrome-coupled antibody. Because many phenotypes
are amenable to detection via specific antibodies, this can be
considered a general assay design theme that, in principle, is
applicable to a wide range of cellular processes.
Data pre-processing and quality
The pre-processing includes import of the result files from the
fluorescence-activated cell sorting (FACS) instrument,
assembly and cleaning up of the data, removal of systematic
biases and drifts (a process often referred to as 'normaliza-
tion'), and transformation to a format and scale that is suita-
ble for the following analysis steps. Here we do not deal with
the technical aspects of data import and management, and
refer the interested reader to the documentation of the soft-
ware package prada for a thorough discussion of these [19].
Selection of well measured cells on the basis of morphology
Most experimental cell populations are contaminated by a
small amount of debris, cell conjugates, buffer precipitates,
and air bubbles. The design of FACS instruments usually does
not allow perfect discrimination of these contaminants from
single, living cells during data acquisition, and hence they can
end up in the raw data. To a certain extent we can discrimi-
nate contaminants from living cells using the morphologic
properties provided by the FSC and SSC parameters. The
joint distribution of FSC and SSC for transformed mamma-
lian cells typically exhibits an elliptical shape, and most con-
taminants separate clearly from this main population (Figure
1a). The core distribution of healthy cells is approximated by
a bivariate normal distribution in the (FSC, SSC) space, allow-
ing the identification of outliers by their low probability den-
sity in that distribution. Thus, measured events that lie
outside a certain density threshold can be regarded as con-
tamination. We fit the bivariate normal distribution to the
data by robust estimation of its center and its 2 × 2 covariance
matrix (Figure 1b). This is appropriate if the cell population is
homogeneous, the proportion of contaminants is small, and
the phenotype of interest is not itself associated with large
changes in the FSC or SSC signal. A rough pre-selection using
some fixed FSC and SSC threshold values, as provided by
most FACS instruments, further increases robustness.
To see how this affects the data, Figure 1 panels c and d show
scatterplots of the two fluorescence channels measuring the
perturbation and the phenotype before and after removal of
contaminants. We observe a reduction in the proportion of
data points with very small fluorescence values in both chan-
nels after removing contaminants. This is reasonable because
the fluorescence staining is intracellular, and hence cell
debris is not expected to emit strong fluorescence. In addi-
tion, we have removed some of the data points with very high
fluorescence levels, which apparently correspond to cell
conjugates.
For our example data it is possible to determine global, exper-
iment-wide parameters of the core distribution of healthy and
well measured cells. However, some experimental settings
may also demand adaptive estimates, for example if the cell
morphology is expected to change as a result of the perturba-
tion (as is the case for apoptotic cells) or if systematic shifts
occur during the course of one experiment.
Correlation of fluorescence and cell size
Regardless of the presence of fluorochromes, every cell emits
light when it is excited by a laser - a phenomenon referred to
as autofluorescence. Autofluorescence intensities frequently
correlate with cell size, and through this effect often spurious
correlations between different fluorescence channels can
occur. In our data, the unspecific autofluorescence adds both
to the specific fluorescence emitted by the fluorochrome-con-
jugated antibody measuring the phenotype and to that of the
YFP-expressing construct, and it is positively correlated with
cell size (Figure 2a,b). This results in an apparent, unspecific
increase in the response variable for higher levels of perturba-
tion (Figure 2c). To recover the specific signal we use FSC as
a proxy for size, and fit the linear model:
xtotal = α + βs + βspecific (1)
Where xtotal is the measured fluorescence intensity, s is the
cell size as measured by the forward light scatter, α and β are
the coefficients of the model, and xspecific is the specific fluo-
rescence. We compute α and β by robust fit of a linear regres-
sion of xtotal on s, and obtain estimates for xspecific from the
residuals (Figure 2d). This is done for each fluorescencehttp://genomebiology.com/2006/7/8/R77 Genome Biology 2006,     Volume 7, Issue 8, Article R77       Hahne et al. R77.3
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channel individually. The artifactual correlation due to
autofluorescence is absorbed by β. The parameter α absorbs
baseline fluorescence, as discussed below.
Systematic variation in signal intensities between wells
In our data we often observe variation in the overall signal
intensities for different wells on a microtiter plate (Figure 3a),
which may be due to various drifts in the equipment, such as
changes in laser power or pipetting efficiencies. Although
such effects should ideally be avoided, and large variations
should prompt reassessment of the experimental setup, small
variations are adjusted by the model described by equation 1.
In particular, they are fitted by the intercept term α. The bio-
logically relevant information is retained in the residuals. A
Selection of well measured cells Figure 1
Selection of well measured cells. (a) Scatterplot of FACS data showing typical properties of morphologic parameters. FSC corresponds to cell size and 
SSC to cell granularity. Several subpopulations can be distinguished: (I) healthy and well measured cells, (II) cell debris, and (III) cell conjugates and air 
bubbles. (b) Robust fit of a bivariate normal distribution to the data. The ellipse represents a contour of equal probability density in the distribution and is 
used as a user-defined cut-off boundary (two standard deviations in this example). Points outside the ellipse (marked in red) are considered contaminants 
and are discarded from further analysis. Scatterplots of perturbation versus phenotype (c) before and (d) after removing contaminants. The proportion of 
outlier data points is reduced significantly. Here, they correspond to measurements with very small phenotype values (cell debris). FACS, fluorescence-
activated cell sorting; FCS, forward light scatter; SSC, sideward light scatter.
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common baseline of the adjusted values is obtained by adding
the mean of α averaged over all wells (Figure 3b).
Statistical inference
Flow cytometry provides individual measurements for each
cell of a population, and so we should like to use statistical
procedures to model the behavior of the whole population
and to draw significant conclusions. Choosing the appropri-
ate statistical model is a crucial step in data analysis because
we want it to represent as many features of the data as possi-
ble without imposing too many assumptions. For different
biologic processes different types of responses can be
expected, and so we also need different models. In our data
we observe two types of response - binary and gradual.
Many biologic processes can be considered on/off switches in
which, after internal or external stimulation above a certain
threshold, a distinct cellular event is triggered (Figure 4a).
This kind of binary response is typical for apoptosis. One key
player of the apoptotic pathway is the enzyme caspase-3,
which is activated at the onset of apoptosis in most cell types.
Activation is rapid and irreversible, and once the cell receives
a signal to undergo apoptosis most or all of its caspase-3 mol-
ecules are proteolytically cleaved. This is the point of no
return, and all subsequent steps inevitably lead to the death
of the cell [20]. Thus, caspase-3 activation is essentially a
binary measure of the apoptotic state of a cell. Similarly, cell
proliferation is regulated in a binary manner, with cells only
progressing further in the cell cycle after reception of appro-
priate signals.
In contrast, many cellular signaling pathways are continu-
ously regulated. The MAPK pathway, which plays a role in cell
cycle regulation, is a prominent example. It consists of several
kinases, enzymes with the ability to phosphorylate other mol-
ecules, in a hierarchical arrangement. By selective phosphor-
ylation and de-phosphorylation reactions a signal can be
passed along the hierarchy [21]. The activity of this pathway
can be continuously regulated both in a positive and in a neg-
ative manner. So, in contrast to apoptosis and cell
proliferation, in which the response is essentially a yes/no
decision, here the response is of a gradual nature (Figure 4b).
Correlation of fluorescence and cell size Figure 2
Correlation of fluorescence and cell size. Empiric cumulative distribution 
functions (ECDF) of fluorescence values for (a) perturbation and (b) 
phenotype showing their positive correlation with cell size. The 
fluorescence values were stratified into subsets corresponding to five 
quantiles (0-20%, 20-40%, 40-60%, 60-80%, and 80-100%) of cell size 
(forward light scatter), and the ECDF for each stratum was plotted in a 
different color. With increasing cell size, an increase in fluorescence values 
is also observed. (c) Regression line fitted to the data showing spurious 
correlation between the two parameters. In this case, the perturbation is 
known to cause no phenotype, and hence the correlation is considered to 
be artifactual. (d) After adjusting for cell size, the two parameters are 
uncorrelated.
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Systematic variation in signal intensities Figure 3
Systematic variation in signal intensities. (a) Box plot of raw fluorescence 
values measuring the phenotype for a 96-well microtiter plate. Differences 
in the mean values are identified for individual wells, and several wells are 
affected by a block effect. (b) Data after normalization.
Response types Figure 4
Response types. (a) Binary response. Above a certain threshold of 
perturbation, a discrete phenotype can be observed. (b) Continuous 
response. The effect size of the phenotype correlates with the amount of 
perturbation. It is typically measured for mild perturbation levels (x0).
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Modeling binary responses
A natural approach to modeling binary responses is to dissect
the data into four subtypes: perturbed versus nonperturbed
cells, and cells exhibiting the effect of interest versus nonre-
sponding cells (Figure 5a). Thresholds for this separation can
be obtained either adaptively, for each well, or more globally,
for the whole plate. Because of the potential problems with
over-fitting in the adaptive approach, we choose the latter,
making use of the premise that the values of the pre-proc-
essed data are comparable across the plate. Figure 5b shows
thresholds determined from a high percentile (99%) of the
data from a negative control.
An estimator for the odds ratio, a measure of the effect size, is
defined by the following equation:
The symbols on the right hand side of equation 2 are defined
in Figure 5a. Pseudo-counts of 1 are added in order to avoid
infinite values in the case of empty quadrants [22]. It is often
convenient to consider the logarithm of the odds ratio,
because it is symmetric for upward and downward effects. To
test for the significance against the null hypothesis of no
effect, we use the Fisher test [23].
Sample results from a screen aiming to identify activators of
the apoptosis pathway are shown in Figure 6. Overexpression
of the Fas receptor protein in Figure 6b leads to strong activa-
tion of apoptosis, as indicated by both high effect size and a
significant P value. This is consistent with the cellular role
played by the Fas receptor, which mediates apoptosis activa-
tion as a consequence of extracellular signaling. Overexpres-
sion of the YFP protein in Figure 6a apparently does not affect
apoptosis, proving that the activation in Figure 6b is not
caused by the fluorescence tag alone.
Modeling continuous responses
The gradual nature of these types of responses supports the
use of regression analysis. Because the effect may deviate
from linearity in the range of perturbations that we observe,
we use a robust local regression fit:
y = m(x) + ε (3)
Where x is the perturbation signal, y is the response, m is a
smooth function (for example, a piece-wise polynomial), and
ε  is a noise term. We obtain an estimate of m  from the
function locfit.robust in the R package locfit [24]. This also
calculates
δ = (4)
which is a robust estimate of the slope of m at the point x0. x0
is an assay-wide, user-defined parameter that corresponds to
a mild perturbation that does not deviate strongly from the
physiologic value. This approach is resistant to nonlinear,
biologically artifactual effects caused by perturbations that
are too strong, without the need for a sharp cut-off. To obtain
a dimensionless measure of effect size, we divide
Where δ0 is a scale parameter of the overall, assay-wide distri-
bution of δ. We use the median absolute value of all δ in the
assay. A simple measure of the significance against the null
hypothesis of no effect is obtained through dividing the
estimate   by its estimated standard deviation, and by
assumption of normality a P value is obtained.
The plots in Figure 7 show the fitted local regression for three
examples from a cell-based assay targeting the MAPK path-
Setup of boundaries Figure 5
Setup of boundaries. (a) Discretization of data showing binary response in 
four subtypes. (b) Mock control used for setup of boundaries.
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way. As a result of the overexpression of the phospholipase C
δ4 (PLCD4) protein, our method detects a significant induc-
tion of extracellular signal-regulated kinase (ERK) activation
(Figure 7a) - a finding that is consistent with previous reports
[25]. As expected, overexpression of the dual specificity pro-
tein phosphatase (DUSP)10 protein strongly inactivates
MAPK signaling (Figure 7b), whereas overexpression of the
YFP protein has no effect (Figure 7c).
Summarizing replicate experiments
The P values obtained from the previous section test the sta-
tistical association between the fluorescence signals from the
overexpressed YFP-tagged proteins and the reporter-specific
antibodies for the cell population in one particular well. It is
important to note that this only takes into account the cell-to-
cell variability within that well and does not reflect higher lev-
els of experimental and biologic variability. Hence, the results
from a single well cannot simply be taken as a measure of bio-
logic significance. To gain confidence in the biologic signifi-
cance of a result, the next step is to consider measurements
over several independently replicated wells.
The most obvious approach to summarizing data from repli-
cate measurements for the same gene is to combine the effect
size estimates and the P values from the individual replicates
using tools from statistical meta-analysis [26]. However,
because all of the data are available, the more direct and prob-
ably more efficient approach is to generalize the previous
analysis methods and to deal with replicate wells. In particu-
lar, for stratified contingency tables in the case of binary
responses, we use the stratified Χ2-statistic in the Cochran-
Mantel-Haenszel test [27]. For stratified continuous
responses we extend equation 3:
y = yi + m(x - xi) + ε (6)
Where i = 1, 2, ... counts over the replicates and xi and yi are
replicate specific offsets. Again, in both cases we obtain esti-
mates of effect size as well as significance.
Interpreting effect size and significance
Because of the large number of tests performed, it is neces-
sary to adjust for multiple testing. Good software for this is
available in the R packages qvalue and multtest, and we rec-
ommend the reports by Storey [28] and Pollard [29] and their
coworkers for methodologic background.
Even after multiple testing adjustment, one will often
encounter situations in which for many of the screened genes
the null hypothesis of no effect will be rejected, although the
effect sizes (equations 2 and 5) may be quite small for most of
them. This can happen because of the large number of cells
observed for each gene, and it is a well known phenomenon of
statistical testing; when the number of data points becomes
large, hypothesis tests will eventually reject any null hypo-
thesis that differs from the truth, even in the most negligible
manner [30]. Such cases are unlikely to be biologically inter-
esting. Hence, for biologically relevant effectors we require
both the effect size estimate to be above a certain threshold
and the adjusted P value to be small.
Finally, as with any biologic assay, to corroborate conclu-
sively the role of a protein in the cellular process of interest,
independent validation experiments must be conducted
according to best experimental practice.
Visualization and quality assessment
Visualization methods exploit the most advanced pattern rec-
ognition system, the human visual system. However, it can
only deal with a limited amount of dimensionality and
complexity, and hence it benefits from assistance by compu-
tational methods for dimension reduction and feature
extraction.
Here, our main focus is on the use of visualization for quality
assessment, which for our kind of data must be done on three
different levels: at the level of the individual well, with resolu-
t i o n  d o w n  t o  d a t a  f r o m  i n d i v i d u a l  c e l l s ;  a t  t h e  l e v e l  o f  a
microtiter plate, with resolution down to individual wells; or
at the level of the gene of interest, which usually comprises
several replicate experiments.
Visualization at the level of individual wells
A simple but useful way to visualize bivariate data is by means
of a scatterplot. However, it is difficult to get a good impres-
sion of the distribution of the data when the number of obser-
vations is large and the points become too dense (Figure 8a).
This is a problem for cytometry data with often more than
20,000 data points. A way to circumvent this limitation
(which has already been applied in some of the previous fig-
ures) is by plotting the densities of the data points at a given
region [31] instead of individual points (Figure 8d) or,
Example results for continuous responses from a MAPK screen Figure 7
Example results for continuous responses from a MAPK screen. Effect size 
z and P value for (a) an activator (PLCD4), (b) a repressor (DUSP10), and 
(c) a non-affector (YFP) of the MAPK signaling. DUSP, dual specificity 
protein phosphatase; MAPK, mitogen-activated protein kinase; PLCD4, 
phospholipase C δ4; YFP, yellow fluorescent protein.
(c)
0 200 600 1000
0
2
0
0
4
0
0
6
0
0
8
0
0
1
0
0
0
perturbation
M
A
P
k
i
n
a
s
e
a
c
t
i
v
a
t
i
o
n
x0
z =0.13 p- value= <2.2e- 16
0 200 600 1000
0
2
0
0
4
0
0
6
0
0
8
0
0
1
0
0
0
perturbation
M
A
P
k
i
n
a
s
e
a
c
t
i
v
a
t
i
o
n
x0
z=-0 . 3 3 p- value= <2.2e- 16
0 200 600 1000
0
2
0
0
4
0
0
6
0
0
8
0
0
1
0
0
0
perturbation
M
A
P
k
i
n
a
s
e
a
c
t
i
v
a
t
i
o
n
x0
z =- 0.001 p-v a l u e =0 . 9 3
(b) (a)http://genomebiology.com/2006/7/8/R77 Genome Biology 2006,     Volume 7, Issue 8, Article R77       Hahne et al. R77.7
c
o
m
m
e
n
t
r
e
v
i
e
w
s
r
e
p
o
r
t
s
r
e
f
e
r
e
e
d
 
r
e
s
e
a
r
c
h
d
e
p
o
s
i
t
e
d
 
r
e
s
e
a
r
c
h
i
n
t
e
r
a
c
t
i
o
n
s
i
n
f
o
r
m
a
t
i
o
n
Genome Biology 2006, 7:R77
alternatively, by plotting each single point using a color cod-
ing that represents the density at its position (Figure 8c). We
prefer false color coding to the commonly used contour plots
(Figure 8b) because we find it more intuitive. By further aug-
menting false color density plots with outlying points, one can
also visualize the data in sparse regions of the plot. We com-
pute densities using a kernel density estimate.
Visualization at the level of microtiter plates
Most high-throughput applications in cell biology are carried
out on microtiter plates which come in different formats, usu-
ally as a rectangular arrangement of 24, 96, 384, or 1536
wells. Each well may contain cells that have been treated in a
different manner. An intuitive approach for visualization is to
use the familiar spatial layout of the plate. Figure 9a shows an
Options to create plots with high point densities Figure 8
Options to create plots with high point densities. (a) Almost no features of the data distribution are visible in the simple scatter plot. (b) The contour plot 
reveals the bimodality of the data. (c) Coloring of points according to point density and (d) density map with additional points in sparse regions.
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example of what we call a plate plot for a 96-well plate. It indi-
cates the number of cells identified in each well. The consist-
ently low number of cells on the edges of the plate suggests a
handling problem, and subsequent analysis steps are possibly
affected by this artifact. Other quantities of interest often
include the average fluorescence of each well, for example to
monitor expression efficiency or to detect artifactual shifts in
the response.
Plate plots can also be used to present qualitative variables.
Figure 9b shows the negative log transformed odds ratios
from the statistical analysis of a 96-well plate from a cell pro-
liferation assay. Negative values indicate inhibition of cell
proliferation and are colored in blue, whereas positive values
correspond to activation as indicated in red. The attention of
the experimenter is immediately drawn to the few interesting
wells and spatial regularities are easily spotted. In this exam-
ple, we can compare the upper and lower halves of the plate;
the top half contains cells transfected with carboxyl-termi-
nally tagged constructs and the bottom half contains cell
transfected with amino-terminally tagged constructs of the
same genes. Additional information is added to the plot by
using further formatting options, for instance crossing out of
wells discarded from analysis or plotting additional symbols
on wells with controls.
The amount of information included in a plate plot can be
extended further by decorating it with tool tips and hyper-
links. When viewed in a browser, a tool tip is a short textual
annotation, for example a gene name, that is displayed when
the mouse pointer moves over a plot element. A hyperlink can
be used to display more detailed information, even a graphic,
in another browser window or frame. For example, underly-
ing each value that is displayed in a plate plot such as Figure
9b is a complex statistical analysis, the details of which can be
displayed on demand by hyperlinking them to the corre-
sponding well icons in the plate plot. The reader is directed to
the online complement [32] for an interactive example. Using
plate plots in this way provides a powerful organizational
structure for drill-down facilities because potentially interest-
ing candidates are easily identified on a plate and the range of
detailed information enables the experimenter to audit steps
of the analysis procedure.
Gene centered visualization
Because experiments are done in replicates, another level of
visualization is needed to compare multiple measurements of
the same gene over several plates. For a limited number of
replicates the plate plot concept can be utilized. Besides
colored circles, as in Figure 9 panels a and b, its implementa-
tion allows us to plot arbitrary graphs at each well position. In
Figure 9c we use segmented charts to display the results from
four replicate experiments (we call this a 'pizza plot'). For
more extensive datasets, Figure 10 shows how hyperlinked
box plots can be used to display multiple relevant aspects of
the data. In this example they allow exploration of the effect
Plate plots show several aspects of the data in a format resembling a  microtiter plate Figure 9
Plate plots show several aspects of the data in a format resembling a 
microtiter plate. This is useful for detecting spatial effects and to present 
concisely the data belonging to one experiment. (a) Quantitative values: 
number of cells in the well. The consistently lower number of cells at the 
edges of the plate indicate problems during cultivation. (b) Qualitative 
values: activators (red) and inhibitors (blue) of the process of interest. 
Wells that did not pass quality requirements are crossed out and wells 
containing cells treated with controls are indicated by capital letters. Cells 
in the first four rows of the plate were transfected with amino-terminally 
tagged expression constructs, and rows five to eight with carboxyl-
terminally tagged constructs. (c) Comparison of results from four 
replicate plates. Each slice contains data from one replicate. 
Reproducibility between replicates is very high.
(a)
4
8
0
8
6
0
1
2
0
0
1
6
0
0
123456789 1 0 1 1 1 2
A
B
C
D
E
F
G
H
(b)
act
inh
−
2
4
−
8
8
2
4
MAN I
T
TT
T
MAN I
C
123456789 1 0 1 1 1 2
A
B
C
D
E
F
G
H
(c)
123456789 1 0 1 1 1 2
A
B
C
D
E
F
G
H
act
inh
−
3
8
−
2
3
−
7
.
4
8
.
1http://genomebiology.com/2006/7/8/R77 Genome Biology 2006,     Volume 7, Issue 8, Article R77       Hahne et al. R77.9
c
o
m
m
e
n
t
r
e
v
i
e
w
s
r
e
p
o
r
t
s
r
e
f
e
r
e
e
d
 
r
e
s
e
a
r
c
h
d
e
p
o
s
i
t
e
d
 
r
e
s
e
a
r
c
h
i
n
t
e
r
a
c
t
i
o
n
s
i
n
f
o
r
m
a
t
i
o
n
Genome Biology 2006, 7:R77
of the orientation of the carboxyl-terminal or amino-terminal
YFP fusion in the expression vectors.
Application
We applied our method to the dataset introduced in the sec-
tion Materials and methods (below) and verified the effects of
positive and negative control genes of known function for
each of the three assays with high specificity (Figure 11), thus
validating the approach. The positive control for the apopto-
sis assay were vectors expressing CIDE3 (cell-death-inducing
DFF45-like effector 3) and the Fas receptor, and the negative
control were vectors expressing cyclin-dependent kinase and
YFP. Positive and negative controls for the proliferation assay
were vectors expressing cyclin A and YFP, respectively. In the
M A P K  a s s a y ,  o v e r e x p r e s s i o n  o f  D U S P 1 0  w a s  u s e d  a s  a
positive control, and overexpression of YFP was used as a
negative control. A total of 273 open reading frames (ORFs)
encoding proteins of unknown function were selected based
on cancer-associated alterations in their respective mRNA
transcription. These ORFs were cloned in 546 amino-termi-
nally as well as carobxyl-terminally fused expression con-
structs and were subsequently screened in the three assays.
Eleven inhibitors and two activators of ERK phosphorylation
were identified in the MAPK assay. The proliferation screen
revealed four activators and five inhibitors. Eleven activators
with significant effect on programmed cell death were
identified in the apoptosis screen. For further details on these
proteins, see Additional data file 1. The complete dataset is
freely available from our web server [32].
Conclusion
The increasing application of high-throughput technologies
in cell biology has opened the way for systematic studies to be
Interactive box plot of effect sizes from replicate experiments for a 96-well plate Figure 10
Interactive box plot of effect sizes from replicate experiments for a 96-well plate. Proteins showing consistently high or low effect sizes can easily be 
identified. By clicking on the individual boxes in the upper panel, a drill-down to the underlying data is provided in the lower panel, which shows the 
individual measurement values for both fluorescence tags as vertical bars along the x-axis. In this example, only the expression of the amino-terminally 
tagged protein results in significantly elevated effect sizes.
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carried out on a large scale. This will allow us to gain an
understanding of complex systems such as cellular pathways,
because of the ability to measure the large number of
parameters needed to model and reconstruct such systems
(for instance, by combinatorial perturbations or time course
experiments). However, the main prerequisite is a uniform,
quantitative and comparable analysis of the raw data in order
to integrate efficiently the information collected. Analyzing
and managing the vast amount of data generated in these
studies initially seems to be a daunting task.
Here, we show the complete work flow from raw flow cytom-
etry data to a list of genes that are components of or interact
with the cellular process of interest. Procedures (methodo-
logic recommendations as well as software) for data pre-
processing are presented that can be used to deal with typical
sources of systematic variation. We stress the importance of
monitoring crucial steps during analysis and show a range of
visualization tools for quality control. Techniques are sug-
gested to assess the data on different levels and to present
results in a concise and meaningful way. By applying statisti-
cal methods, we are able to identify interesting phenotypes
based on a set of objective criteria rather than relying on man-
ual selections. Because data are available for each cell of a cell
population, we are able to extract several kinds of
information. Stratified statistical tests and models allow us to
combine results from replicate experiments, further increas-
ing precision.
To select genes of interest we consider two parameters, a
threshold for the P value as well as one for the effect size. It is
important to note that statistical significance and effect size
are independent quantities, and that we must impose
conditions on both of them if we are to obtain relevant results.
In our screen the main focus lies on identifying candidates out
of a pool of functionally unknown genes for further, in-depth
analyses; thus, specificity is given preference over sensitivity,
which is reflected in a rather conservative selection of thresh-
old values.
Some of the methods described here are specific to flow
cytometry measurements, but most of the visualization
should also be applicable to data from other sources. Here we
have only considered two simple models: binary and continu-
ous responses. However, cell-based assays can be designed to
assess almost any cellular process, and as the complexity of
Separation of positive and negative controls Figure 11
Separation of positive and negative controls. Top panels: effect sizes of positive and negative controls (y-axis) for individual plates (x-axis). Bottom panels: 
density plots of the joint effect sizes for controls across all plates. (a) Controls for the apoptosis assay are CIDE3 (positive) and CDK (negative). (b) 
Controls for the proliferation assay are cyclin A (positive) and YFP (negative). (c) Controls for the MAPK assay are DUSP10 (positive) and YFP (negative). 
The measured effect sizes for positive and negative controls separate well. CDK, cyclin-dependent kinase; DUSP, dual specificity protein phosphatase; 
MAPK, mitogen-activated protein kinase; YFP, yellow fluorescent protein.
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the observed phenotypes increase, so do the necessary statis-
tical models. However, there will always be a need to
summarize and simplify data to a form that is amenable to
visual inspection and that allows for drill-down to more
detailed aspects. In addition to specified analyses, we also
wish to provide a framework that is easily adaptable and
extendable to more complex assays and phenotypes.
All functionality is implemented using the statistical pro-
gramming language R and is available as the software pack-
age prada through the open source Bioconductor project [19].
Materials and methods
A total of 273 ORFs encoding proteins of unknown function
were selected based on cancer-associated alterations in their
respective mRNA transcription [33]. HEK 293T cells were
transfected with expression constructs of the respective genes
of interest fused to the YFP under the control of a cytomega-
lovirus promoter [34]. The amino-terminal or carboxyl-ter-
minal fluorescence tags allowed us to monitor the level of
expression along with the detection of induced effects. Cells
were fixed 48 hours (MAPK and DNA replication assay) or 72
hours (apoptosis assay) after transfection and stained intrac-
ellularly with specific antibodies. Different antibodies were
used for the different assays, each specifically measuring the
phenotype of interest. In the case of cell proliferation, the
antibody detected the incorporation of the thymidine analog
BrdU into the replicated DNA. An antibody specific for the
activated form of the caspase-3 apoptosis regulator was
employed in the apoptosis assay; a phospho-specific antibody
detecting phosphorylated ERK2 was used to measure activa-
tion of MAPK signaling. The same secondary antibody cou-
pled to Allophycocyanin (APC) was used for immunostaining
in all three assays. Flow cytometry data were acquired using
an automated FACS instrument (BD FACS Calibur, Becton
Dickinson Biosciences, 2350 Qume Drive, San Jose, Ca,
USA).
Additional data file
The following additional data are included with the online
version of this article: The vignette of the accompanying R
data package containing code samples and a more detailed
description of the individual computational analysis steps, as
well as tables of the candidates from our dataset identified in
the three assays (Additional data file 1).
Additional data file 1 Sample analysis of cell-based screens The vignette of the accompanying R data package containing code  samples and a more detailed description of the individual compu- tational analysis steps, as well as tables of the candidates from our  dataset identified in the three assays. Click here for file
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